{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T05:10:04Z","timestamp":1775279404104,"version":"3.50.1"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,16]]},"abstract":"<jats:p>Pachyonychia congenita (PC) is a rare genodermatosis characterized by focal palmoplantar keratoderma, severe plantar pain and dystrophic nails. Anecdotally, some patients with PC have erythematous soles and episodic burning plantar pain, indicative of secondary erythromelalgia. This study aimed to identify the prevalence and genetic predictors of erythromelalgia in PC.<\/jats:p>","DOI":"10.1093\/bjd\/ljae143","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T03:29:15Z","timestamp":1712546955000},"page":"300-302","source":"Crossref","is-referenced-by-count":1,"title":["A cross-sectional study of erythromelalgia in patients with pachyonychia congenita"],"prefix":"10.1093","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7126-8384","authenticated-orcid":false,"given":"Rebecca L","family":"McCarthy","sequence":"first","affiliation":[{"name":"Centre for Cell Biology and Cutaneous Research, Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London , London , UK"},{"name":"Department of Dermatology, Royal London Hospital, Barts Health NHS Trust , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janice","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Pachyonychia Congenita Project , Salt Lake City, UT , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9772-3218","authenticated-orcid":false,"given":"Jaimie","family":"Oldham","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Royal London Hospital, Barts Health NHS Trust , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Bodemer","sequence":"additional","affiliation":[{"name":"Reference Center for Genodermatoses (MAGEC), Department of Dermatology, APHP, H\u00f4pital Necker-Enfants Malades , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celine","family":"Greco","sequence":"additional","affiliation":[{"name":"Department of Pain and Palliative Care , H\u00f4pital Necker-Enfants Malades, Paris , France"},{"name":"ATIP\/Avenir Team \u2018Targeted Pain Therapy and Drug Repurposing in Genetic Skin Diseases\u2019, U1163 INSERM, Imagine Institut , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Hovnanian","sequence":"additional","affiliation":[{"name":"INSERM UMR 1163, Universit\u00e9 Paris Cit\u00e9, Laboratory of Genetic Skin Diseases, Imagine Institute , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C \u00a0David","family":"Hansen","sequence":"additional","affiliation":[{"name":"Pachyonychia Congenita Project , Salt Lake City, UT , USA"},{"name":"Department of Dermatology, University of Utah , Salt Lake City, UT , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edel A","family":"O\u2019Toole","sequence":"additional","affiliation":[{"name":"Centre for Cell Biology and Cutaneous Research, Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London , London , UK"},{"name":"Department of Dermatology, Royal London Hospital, Barts Health NHS Trust , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"2024071611283704900_ljae143-B1","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaad.2011.12.009","article-title":"A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita","volume":"67","author":"Eliason","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"2024071611283704900_ljae143-B2","first-page":"249","article-title":"Erythromelalgia","volume":"144","author":"Thompson","year":"1979","journal-title":"Clin Orthop Relat Res"},{"key":"2024071611283704900_ljae143-B3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/ced.13891","article-title":"Review of primary and secondary erythromelalgia","volume":"44","author":"Mann","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"2024071611283704900_ljae143-B4","author":"Pachyonychia Congenita Project"},{"key":"2024071611283704900_ljae143-B5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/jamadermatol.2013.8709","article-title":"A new TRPV3 missense mutation in a patient with Olmsted syndrome and erythromelalgia","volume":"150","author":"Duchatelet","year":"2014","journal-title":"JAMA Dermatol"},{"key":"2024071611283704900_ljae143-B6","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1038\/jid.2015.217","article-title":"Expanding the phenotypic spectrum of Olmsted syndrome","volume":"135","author":"Wilson","year":"2015","journal-title":"J Invest Dermatol"},{"key":"2024071611283704900_ljae143-B7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/bjd.12951","article-title":"Olmsted syndrome with erythromelalgia caused by recessive transient receptor potential vanilloid 3 mutations","volume":"171","author":"Duchatelet","year":"2014","journal-title":"Br J Dermatol"},{"key":"2024071611283704900_ljae143-B8","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jid.2022.08.045","article-title":"EGFR signaling is overactive in pachyonychia congenita: effective treatment with oral erlotinib","volume":"143","author":"Basset","year":"2023","journal-title":"J Invest Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljae143\/57954892\/ljae143.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/191\/2\/300\/58554286\/ljae143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/191\/2\/300\/58554286\/ljae143.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T11:29:01Z","timestamp":1721129341000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/191\/2\/300\/7641922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":8,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,4,8]]},"published-print":{"date-parts":[[2024,7,16]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljae143","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,4,8]]}}}